Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.814.86-11.939.9461.19

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 19.81 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.81
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.81
307.61
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹26,776.3 Cr 1.9% -0.8% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

1.9%

-0.8%

4.2%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses